Related Experiment Video

Updated: Apr 5, 2026

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.6K

Emerging Drug Target In Pancreatic Cancer: Placing Sirtuin 1 on the Canvas

Marc Giry-Laterriere, Andreia V Pinho, Nils Eling

  • 1The Garvan Institute of Medical Research, Sydney, Australia. i.rooman@garvan.org.au.

Current Cancer Drug Targets
|August 19, 2015
PubMed

Insights

Sirtuin 1 (SIRT1) shows promise as a cancer therapy target. Inhibitors are being explored for pancreatic cancer, a disease with limited treatment options, by examining SIRT1

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Sirtuin 1 (SIRT1) is a protein deacetylase regulating proteins involved in tumor development.
  • SIRT1's diverse functions make it a potential target for cancer therapies.
  • Preclinical studies show promise for SIRT1 inhibitors in chronic myeloid leukemia treatment.

Purpose of the Study:

  • To explore the potential of Sirtuin 1 (SIRT1) as a therapeutic target in pancreatic cancer.
  • To identify common SIRT1 target genes implicated in pancreatic cancer based on genomic data.

Main Methods:

  • Review of existing studies on SIRT1 in cancer therapy.
  • Analysis of recent genomic data for pancreatic cancer to identify SIRT1-affected genes.

Main Results:

  • SIRT1 is a promising therapeutic target for pancreatic cancer.
  • Genomic analyses reveal common SIRT1 target genes in pancreatic tumors.

Conclusions:

  • SIRT1 inhibitors represent a potential new therapeutic strategy for pancreatic cancer.
  • Targeting SIRT1 may offer a novel approach for treating this difficult-to-treat cancer.

More Related Videos

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.3K
Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma06:21

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Published on: November 19, 2019

12.5K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K